10/31/14 DVA 78.07 Davita Healthcare Partners Inc $DVA Hit a 52 week high of 78.52 Closing the day 10/31/14 at 78.07 +0.45 +0.58% With a day low of 77.75 and a total volume of 793,300.
DVA Recent Posts: http://investorshangout.com/Davita-Inc-DVA-50803/
DVA Davita Healthcare Partners Inc Recent Headline News
DaVita Kidney Care Shares Festive Halloween Recipes
PR Newswire - Fri Oct 31, 5:24AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, shares a collection of Halloween recipes that are tasty alternatives for individuals on a kidney-friendly diet.
DVA: 78.07 (+0.45)
Health Care Services Stocks Highlight - Express Scripts Holding, Omnicare, MEDNAX, DaVita HealthCare Partners, and Quest Diagnostics
PR Newswire - Wed Oct 29, 8:05AM CDT
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Co. (NASDAQ: ESRX), Omnicare Inc. (NYSE: OCR), MEDNAX Inc. (NYSE: MD), DaVita HealthCare Partners Inc. (NYSE: DVA), and Quest Diagnostics Inc. (NYSE: DGX). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, October 28, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,005.75, up 1.12% and the NASDAQ Composite closed at 4,564.29, up 1.75%. The S&P 500 finished the session 1.19% higher at 1,985.05. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 760.91, up 0.74%, with the index advancing 6.21% in the previous three months. Register for your complimentary reports on these five stocks at:
OCR: 66.59 (+0.29), ESRX: 76.82 (+1.28), DVA: 78.07 (+0.45), DGX: 63.46 (-0.02), MD: 62.43 (+0.93)
Why DaVita Healthcare Partners Inc. is 1 of the Biggest Warren Buffett Stocks
Selena Maranjian, The Motley Fool - Motley Fool - Wed Oct 29, 7:31AM CDT
Dialysis patient. Source: DaVita Healthcare Partners If you're in the market for some great stock ideas for your portfolio, it makes sense to study what the smartest and most successful investors own. Few, if any, investors are smarter or more...
DVA: 78.07 (+0.45)
DaVita Rx Opens State-of-the-Art Orlando Pharmacy
PR Newswire - Wed Oct 29, 5:23AM CDT
DaVita Rx, a full-service pharmacy created for patients with complex chronic conditions, such as those with kidney disease, announced today the grand opening of its new Orlando, Florida, pharmacy.
DVA: 78.07 (+0.45)
23.3% Return Seen to Date on SmarTrend DaVita Call (DVA)
Comtex SmarTrend(R) - Mon Oct 27, 9:16AM CDT
SmarTrend identified an Uptrend for DaVita (NYSE
VA) on December 10th, 2013 at $62.16. In approximately 11 months, DaVita has returned 23.26% as of today's recent price of $76.62.
DVA: 78.07 (+0.45)
DaVita Kidney Care Finalizes DOJ Settlement
PR Newswire - Wed Oct 22, 7:01PM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA), today announced it has finalized its comprehensive settlement with the U.S. Department of Justice and certain other federal agencies regarding allegations of improperly structured joint ventures with certain physician partners.
DVA: 78.07 (+0.45)
DaVita HealthCare Partners to Acquire Colorado Springs Health Partners
PR Newswire - Wed Oct 22, 5:38AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), a leading provider of population health and kidney care services, today announced that HealthCare Partners has entered into an agreement to acquire Colorado Springs Health Partners (CSHP), a multi-specialty medical group with more than 100 physicians at 11 locations throughout the Pikes Peak region.
DVA: 78.07 (+0.45)
Dr. John Wigneswaran Joins Team at DaVita Kidney Care
PR Newswire - Tue Oct 21, 5:42AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the company has named John Wigneswaran, M.D., as its new vice president of clinical affairs for hospital services.
DVA: 78.07 (+0.45)
DaVita Has Returned 17.0% Since SmarTrend Recommendation (DVA)
Comtex SmarTrend(R) - Fri Oct 17, 5:09PM CDT
SmarTrend identified an Uptrend for DaVita (NYSE VA) on December 10th, 2013 at $62.16. In approximately 10 months, DaVita has returned 17.04% as of today's recent price of $72.75.
DVA: 78.07 (+0.45)
DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone
PR Newswire - Fri Oct 17, 5:06AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), one of the nation's largest and most innovative health care communities, recently held its 150th DaVita University Academy - the company's award-winning, leadership development and cultural orientation program for new teammates. Nearly 2,000 DaVita teammates from around the globe were in attendance for the event.
DVA: 78.07 (+0.45)
DaVita HealthCare Partners Inc. Schedules 3rd Quarter 2014 Investor Conference Call
PR Newswire - Thu Oct 16, 5:00PM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA) announced today that it will hold its quarterly conference call to discuss third quarter results on Thursday, Nov. 6, 2014, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.
DVA: 78.07 (+0.45)
Harvard Business Review Recognizes DaVita HealthCare Partners
PR Newswire - Thu Oct 16, 3:50PM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), one of the nation's largest and most innovative health care communities, today announced that the Reputation Institute ranked DaVita HealthCare Partners 37th overall in its global rankings, according to a recent article in Harvard Business Review (HBR).
DVA: 78.07 (+0.45)
DaVita Kidney Care Response Team Celebrates Decade of Success
PR Newswire - Wed Oct 15, 5:04AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, is celebrating the 10-year anniversary of the DaVita Village Emergency Response Team's (DaVERT) preparation for and response to various natural and manmade disasters that have impacted kidney care patients around the country.
DVA: 78.07 (+0.45)
VillageHealth Disease Management Accredited by National Committee for Quality Assurance
PR Newswire - Tue Oct 14, 5:13AM CDT
Village Health, a strategic business unit of DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, has received Disease Management Accreditation from the National Committee for Quality Assurance (NCQA) for its Renal Disease Management program. The program scored a 99.23 out of a possible 100.
DVA: 78.07 (+0.45)
Dr. Lorne Holland Joins DaVita Labs as Chief Lab Officer
PR Newswire - Mon Oct 13, 5:03AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that DaVita Labs, the diagnostic laboratory servicing both dialysis organizations and physician practices, has named Lorne L. Holland, M.D., M.B.A., as its new chief laboratory officer (CLO).
DVA: 78.07 (+0.45)
DaVita Shares Up 19.7% Since SmarTrend's Buy Recommendation (DVA)
Comtex SmarTrend(R) - Fri Oct 10, 11:12AM CDT
SmarTrend identified an Uptrend for DaVita (NYSE VA) on December 10th, 2013 at $62.16. In approximately 10 months, DaVita has returned 19.66% as of today's recent price of $74.38.
DVA: 78.07 (+0.45)
DaVita HealthCare Partners Recognized by Congressional Black Caucus Foundation
PR Newswire - Tue Oct 07, 5:03AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), one of the nation's largest and most innovative health care communities, was recently recognized by the Congressional Black Caucus (CBC) Foundation with the 2014 CBC Fall Health Braintrust Corporate Leadership Award.
DVA: 78.07 (+0.45)
DaVita Kidney Care Offers Fall Cookbook
PR Newswire - Mon Oct 06, 5:17AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners (NYSE: DVA) and a leading provider of kidney care services announced the availability of its fall cookbook, a collection that incorporates recipes with fall fruit and vegetables as well as whole grains that can be included in kidney diet recipes.
DVA: 78.07 (+0.45)
Uptrend Call Working As DaVita Stock Rises 18.8% (DVA)
Comtex SmarTrend(R) - Fri Oct 03, 9:20AM CDT
SmarTrend identified an Uptrend for DaVita (NYSE VA) on December 10th, 2013 at $62.16. In approximately 10 months, DaVita has returned 18.79% as of today's recent price of $73.84.
DVA: 78.07 (+0.45)
DaVita's Acquisitions Look Promising, High Debt a Concern - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 9:20AM CDT
On Sep 30, we issued an updated research report on DaVita HealthCare Partners Inc. (DVA).
AFAM: 29.44 (+0.69), DVA: 78.07 (+0.45), LHCG: 24.35 (+0.03), GTIV: 19.70 (+0.06)
DVA Recent Posts: http://investorshangout.com/Davita-Inc-DVA-50803/
DVA Davita Healthcare Partners Inc Recent Headline News
DaVita Kidney Care Shares Festive Halloween Recipes
PR Newswire - Fri Oct 31, 5:24AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, shares a collection of Halloween recipes that are tasty alternatives for individuals on a kidney-friendly diet.
DVA: 78.07 (+0.45)
Health Care Services Stocks Highlight - Express Scripts Holding, Omnicare, MEDNAX, DaVita HealthCare Partners, and Quest Diagnostics
PR Newswire - Wed Oct 29, 8:05AM CDT
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Co. (NASDAQ: ESRX), Omnicare Inc. (NYSE: OCR), MEDNAX Inc. (NYSE: MD), DaVita HealthCare Partners Inc. (NYSE: DVA), and Quest Diagnostics Inc. (NYSE: DGX). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, October 28, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,005.75, up 1.12% and the NASDAQ Composite closed at 4,564.29, up 1.75%. The S&P 500 finished the session 1.19% higher at 1,985.05. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 760.91, up 0.74%, with the index advancing 6.21% in the previous three months. Register for your complimentary reports on these five stocks at:
OCR: 66.59 (+0.29), ESRX: 76.82 (+1.28), DVA: 78.07 (+0.45), DGX: 63.46 (-0.02), MD: 62.43 (+0.93)
Why DaVita Healthcare Partners Inc. is 1 of the Biggest Warren Buffett Stocks
Selena Maranjian, The Motley Fool - Motley Fool - Wed Oct 29, 7:31AM CDT
Dialysis patient. Source: DaVita Healthcare Partners If you're in the market for some great stock ideas for your portfolio, it makes sense to study what the smartest and most successful investors own. Few, if any, investors are smarter or more...
DVA: 78.07 (+0.45)
DaVita Rx Opens State-of-the-Art Orlando Pharmacy
PR Newswire - Wed Oct 29, 5:23AM CDT
DaVita Rx, a full-service pharmacy created for patients with complex chronic conditions, such as those with kidney disease, announced today the grand opening of its new Orlando, Florida, pharmacy.
DVA: 78.07 (+0.45)
23.3% Return Seen to Date on SmarTrend DaVita Call (DVA)
Comtex SmarTrend(R) - Mon Oct 27, 9:16AM CDT
SmarTrend identified an Uptrend for DaVita (NYSE
VA) on December 10th, 2013 at $62.16. In approximately 11 months, DaVita has returned 23.26% as of today's recent price of $76.62. DVA: 78.07 (+0.45)
DaVita Kidney Care Finalizes DOJ Settlement
PR Newswire - Wed Oct 22, 7:01PM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA), today announced it has finalized its comprehensive settlement with the U.S. Department of Justice and certain other federal agencies regarding allegations of improperly structured joint ventures with certain physician partners.
DVA: 78.07 (+0.45)
DaVita HealthCare Partners to Acquire Colorado Springs Health Partners
PR Newswire - Wed Oct 22, 5:38AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), a leading provider of population health and kidney care services, today announced that HealthCare Partners has entered into an agreement to acquire Colorado Springs Health Partners (CSHP), a multi-specialty medical group with more than 100 physicians at 11 locations throughout the Pikes Peak region.
DVA: 78.07 (+0.45)
Dr. John Wigneswaran Joins Team at DaVita Kidney Care
PR Newswire - Tue Oct 21, 5:42AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the company has named John Wigneswaran, M.D., as its new vice president of clinical affairs for hospital services.
DVA: 78.07 (+0.45)
DaVita Has Returned 17.0% Since SmarTrend Recommendation (DVA)
Comtex SmarTrend(R) - Fri Oct 17, 5:09PM CDT
SmarTrend identified an Uptrend for DaVita (NYSE
VA) on December 10th, 2013 at $62.16. In approximately 10 months, DaVita has returned 17.04% as of today's recent price of $72.75. DVA: 78.07 (+0.45)
DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone
PR Newswire - Fri Oct 17, 5:06AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), one of the nation's largest and most innovative health care communities, recently held its 150th DaVita University Academy - the company's award-winning, leadership development and cultural orientation program for new teammates. Nearly 2,000 DaVita teammates from around the globe were in attendance for the event.
DVA: 78.07 (+0.45)
DaVita HealthCare Partners Inc. Schedules 3rd Quarter 2014 Investor Conference Call
PR Newswire - Thu Oct 16, 5:00PM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA) announced today that it will hold its quarterly conference call to discuss third quarter results on Thursday, Nov. 6, 2014, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.
DVA: 78.07 (+0.45)
Harvard Business Review Recognizes DaVita HealthCare Partners
PR Newswire - Thu Oct 16, 3:50PM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), one of the nation's largest and most innovative health care communities, today announced that the Reputation Institute ranked DaVita HealthCare Partners 37th overall in its global rankings, according to a recent article in Harvard Business Review (HBR).
DVA: 78.07 (+0.45)
DaVita Kidney Care Response Team Celebrates Decade of Success
PR Newswire - Wed Oct 15, 5:04AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, is celebrating the 10-year anniversary of the DaVita Village Emergency Response Team's (DaVERT) preparation for and response to various natural and manmade disasters that have impacted kidney care patients around the country.
DVA: 78.07 (+0.45)
VillageHealth Disease Management Accredited by National Committee for Quality Assurance
PR Newswire - Tue Oct 14, 5:13AM CDT
Village Health, a strategic business unit of DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, has received Disease Management Accreditation from the National Committee for Quality Assurance (NCQA) for its Renal Disease Management program. The program scored a 99.23 out of a possible 100.
DVA: 78.07 (+0.45)
Dr. Lorne Holland Joins DaVita Labs as Chief Lab Officer
PR Newswire - Mon Oct 13, 5:03AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that DaVita Labs, the diagnostic laboratory servicing both dialysis organizations and physician practices, has named Lorne L. Holland, M.D., M.B.A., as its new chief laboratory officer (CLO).
DVA: 78.07 (+0.45)
DaVita Shares Up 19.7% Since SmarTrend's Buy Recommendation (DVA)
Comtex SmarTrend(R) - Fri Oct 10, 11:12AM CDT
SmarTrend identified an Uptrend for DaVita (NYSE
VA) on December 10th, 2013 at $62.16. In approximately 10 months, DaVita has returned 19.66% as of today's recent price of $74.38. DVA: 78.07 (+0.45)
DaVita HealthCare Partners Recognized by Congressional Black Caucus Foundation
PR Newswire - Tue Oct 07, 5:03AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), one of the nation's largest and most innovative health care communities, was recently recognized by the Congressional Black Caucus (CBC) Foundation with the 2014 CBC Fall Health Braintrust Corporate Leadership Award.
DVA: 78.07 (+0.45)
DaVita Kidney Care Offers Fall Cookbook
PR Newswire - Mon Oct 06, 5:17AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners (NYSE: DVA) and a leading provider of kidney care services announced the availability of its fall cookbook, a collection that incorporates recipes with fall fruit and vegetables as well as whole grains that can be included in kidney diet recipes.
DVA: 78.07 (+0.45)
Uptrend Call Working As DaVita Stock Rises 18.8% (DVA)
Comtex SmarTrend(R) - Fri Oct 03, 9:20AM CDT
SmarTrend identified an Uptrend for DaVita (NYSE
VA) on December 10th, 2013 at $62.16. In approximately 10 months, DaVita has returned 18.79% as of today's recent price of $73.84. DVA: 78.07 (+0.45)
DaVita's Acquisitions Look Promising, High Debt a Concern - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 9:20AM CDT
On Sep 30, we issued an updated research report on DaVita HealthCare Partners Inc. (DVA).
AFAM: 29.44 (+0.69), DVA: 78.07 (+0.45), LHCG: 24.35 (+0.03), GTIV: 19.70 (+0.06)
